| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 380 |
| 1 | PREDNISONE | 76 |
| 2 | AZATHIOPRINE | 67 |
| 3 | ACETAMINOPHEN | 61 |
| 4 | OMEPRAZOLE MAGNESIUM | 58 |
| 5 | ASPIRIN | 57 |
| 6 | ASPIRIN 325 MG | 55 |
| 7 | ASPIRIN 81 MG | 55 |
| 8 | OMEPRAZOLE | 48 |
| 9 | MYCOPHENOLATE MOFETIL | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NYSTATIN TOPICAL POWDER | 1 | 0.0312 |
| 1 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 2 | LAZERTINIB | 6 | 0.0069 |
| 3 | ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL | 1 | 0.0064 |
| 4 | ZOLBETUXIMAB | 9 | 0.0059 |
| 5 | TEPOTINIB HYDROCHLORIDE | 4 | 0.0058 |
| 6 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 7 | DIMETICONE | 1 | 0.0035 |
| 8 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 9 | ERAVACYCLINE | 1 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 210 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 160 |
| 2 | Proton Pump Inhibitor [EPC] | 84 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 81 |
| 4 | Purine Antimetabolite [EPC] | 70 |
| 5 | Platinum-based Drug [EPC] | 68 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 66 |
| 7 | Vitamin C [EPC] | 64 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 58 |
| 9 | Benzodiazepine [EPC] | 57 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 9 | 0.0059 |
| 1 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 8 | 0.0013 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 3 | 0.0013 |
| 4 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 5 | GLP-2 Analog [EPC] | 14 | 0.0010 |
| 6 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 7 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 8 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 9 | Chloride Channel Activator [EPC] | 8 | 0.0008 |